Questions serious traders ask before they start.

A broker-agnostic decision workspace for stocks and options. It helps serious traders find ideas, inspect diagnostics, review hypothetical results, and carry the reasoning forward before handing execution to their broker.

No. PredictDesk is not a broker, does not custody assets, and does not provide investment advice or recommendations.

Yes. PredictDesk supports both stocks and options in one workflow. The right expression for an idea may be a stock position or an options structure.

PredictDesk is not another charting stack, screener, or isolated backtest page. It scans for qualified setups, explains the tradeoffs, shows what nearly qualified, and carries the reasoning forward instead of forcing you to restart at every step.

Strategy Lab is where the idea earns its place. It gives you a shortlist you can rank, near misses you can inspect, diagnostics you can challenge, and full strategy configurations you can carry forward.

They explain why an idea qualified, why something almost qualified, and what tradeoffs changed the result. That context is a core differentiator, not an afterthought.

Yes, but they should always be read as hypothetical research outputs rather than promises of future results.

You join the waitlist for updates and an email when broader beta signup opens. Joining the waitlist does not create product access or begin billing. When your cohort opens, you can return, review the plans, and decide whether to subscribe.

Research is the complete research desk for one serious trader. Pro keeps that desk and adds seamless monitoring, live routing context, workflow continuity, and route-and-signal-oriented handoff for heavier individual use.

Choose Desk when the buyer is a team, firm, or desk and needs shared workflows, governance, onboarding, entitlements, or a contact-led operating path.

You add your email for product updates and a cohort notice. Joining the waitlist does not create product access, start a trial, or begin billing.

Not when you join the waitlist. If your cohort opens later, you review the plan and billing details before deciding whether to subscribe.

Cancellation and renewal terms are shown clearly before signup so you can review them before you commit.

PredictDesk is invite-only right now. You can review the product direction and pricing, join the waitlist, and wait for a cohort notice before deciding whether to subscribe.

Because this is a serious trading workflow product. Options involve significant risk. Backtests are hypothetical. The boundaries should be clear.

In some cases. Professional usage may require additional rights. Desk is the right path when that matters.

No. PredictDesk is not marketing closed-loop unattended execution at launch. The public product story is research, diagnostics, continuity, monitoring, and broker-agnostic handoff.

Equities and options scans and backtests typically use up to ~3 years of historical data, depending on the symbol, structure, and interval. This is disclosed throughout the product.

No. Diagnostics show why something qualified, what tradeoffs changed the result, which metrics were near thresholds, and how near misses compare. The reasoning is visible.

Yes. PredictDesk is broker-agnostic. You keep your broker and remain responsible for execution and risk decisions.

We email you when your cohort opens so you can return, review the plans, and decide whether to subscribe.

Yes. The workflow is built to support intraday-focused traders and traders holding positions over days or weeks.